Endothelial dysfunction is an early and pre-clinical manifestation of coronary heart disease (CHD).
OBJECTIVE:
This study investigates the role of DDX5 in oxidized low-density lipoprotein (ox-LDL)-induced endothelial cell injury to confer novel targets for the treatment of CHD.
METHODS:
Endothelial cells were induced by ox-LDL. DDX5, pri-miR-640, pre-miR-640, miR-640, and SOX6 expressions were analyzed by RT-qPCR and Western blot. DDX5 expression was intervened by shRNA, followed by CCK-8 analysis of proliferation, flow cytometry detection of apoptosis, and tube formation assay analysis of angiogenic potential of cells. The binding between DDX5 and pri-miR-640 was determined by RIP, and the pri-miR-640 RNA stability was measured after actinomycin D treatment. Dual-luciferase assay verified the targeting relationship between miR-640 and SOX6.
RESULTS:
DDX5 and miR-640 were highly expressed while SOX6 was poorly expressed in ox-LDL-induced endothelial cells. Silence of DDX5 augmented cell proliferation, abated apoptosis, and facilitated angiogenesis. Mechanistically, RNA binding protein DDX5 elevated miR-640 expression by weakening the degradation of pri-miR-640, thereby reducing SOX6 expression. Combined experimental results indicated that overexpression of miR-640 or low expression of SOX6 offset the protective effect of DDX5 silencing on cell injury.
CONCLUSION:
DDX5 elevates miR-640 expression by repressing the degradation of pri-miR-640 and then reduces SOX6 expression, thus exacerbating ox-LDL-induced endothelial cell injury.
BockusL, KimF. Coronary endothelial dysfunction: from pathogenesis to clinical implications. Open Heart. 2022;9(2).
5.
YanP, SunC, MaJ, JinZ, GuoR, YangB. MicroRNA-128 confers protection against cardiac microvascular endothelial cell injury in coronary heart disease via negative regulation of IRS1. J Cell Physiol. 2019;234(8):13452–63.
6.
GutierrezE, FlammerAJ, LermanLO, ElizagaJ, LermanA, Fernandez-AvilesF. Endothelial dysfunction over the course of coronary artery disease. Eur Heart J. 2013;34(41):3175–81.
7.
MatsuzawaY, GuddetiRR, KwonTG, LermanLO, LermanA. Treating coronary disease and the impact of endothelial dysfunction. Prog Cardiovasc Dis. 2015;57(5):431–42.
8.
XingZ, MaWK, TranEJ. The DDX5/Dbp2 subfamily of DEAD-box RNA helicases. Wiley Interdiscip Rev RNA. 2019;10(2):e1519.
9.
DardenneE, Polay EspinozaM, FattetL, GermannS, LambertMP, NeilH, et al.RNA helicases DDX5 and DDX17 dynamically orchestrate transcription, miRNA, and splicing programs in cell differentiation. Cell Rep. 2014;7(6):1900–13.
10.
HuM, ZhengH, WuJ, SunY, WangT, ChenS. DDX5: an expectable treater for viral infection- a literature review. Ann Transl Med. 2022;10(12):712.
11.
DimmelerS, HaendelerJ, GalleJ, ZeiherAM. Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases. A mechanistic clue to the ‘response to injury’ hypothesis. Circulation. 1997;95(7):1760–3.
12.
KontushA, ChancharmeL, Escargueil-BlancI, TherondP, SalvayreR, Negre-SalvayreA, et al.Mildly oxidized LDL particle subspecies are distinct in their capacity to induce apoptosis in endothelial cells: role of lipid hydroperoxides. FASEB J. 2003;17(1):88–90.
13.
ZhaoW, WangZ, SunZ, HeY, JianD, HuX, et al.RNA helicase DDX5 participates in oxLDL-induced macrophage scavenger receptor 1 expression by suppressing mRNA degradation. Exp Cell Res. 2018;366(2):114–20.
14.
WojciechowskaA, BraniewskaA, Kozar-KaminskaK. MicroRNA in cardiovascular biology and disease. Adv Clin Exp Med. 2017;26(5):865–74.
15.
ZhangZ, QinS, WangR, FangZ, WangY, LiF. Circ_000575 knockdown alleviates ox-LDL-induced human aortic endothelial cell dysfunction in atherosclerosis by miR-637/TRAF6 axis. Clin Hemorheol Microcirc. 2023;85(2):173–87.
16.
WangY, LiuP, ChenX, YangW. Circ_CHMP5 aggravates oxidized low-density lipoprotein-induced damage to human umbilical vein endothelial cells through miR-516b-5p/TGFbetaR2 axis. Clin Hemorheol Microcirc. 2023;85(4):325–39.
17.
HeD, LiZ, ChenY, HuangM. Circular RNA circ_0029589 promotes ox-LDL-induced endothelial cell injury through regulating RAB22A by serving as a sponge of miR-1197. Clin Hemorheol Microcirc. 2023;83(4):359–76.
18.
CaiY, XuL, XuC, WangY, FanC. Hsa_circ_0001445 inhibits ox-LDL-induced HUVECs inflammation, oxidative stress and apoptosis by regulating miRNA-640. Perfusion. 2022;37(1):86–94.
19.
ShengY, YangZ, FengZ, WangY, JiN. MicroRNA-499-5p promotes vascular smooth muscle cell proliferation and migration via inhibiting SOX6. Physiol Genomics. 2023;55(2):67–74.
20.
SaleemM, Barturen-LarreaP, GomezJA. Emerging roles of Sox6 in the renal and cardiovascular system. Physiol Rep. 2020;8(22):e14604.
21.
SaleemM, RahmanS, ElijovichF, LafferCL, ErtugluLA, MasengaSK, et alSox6, A Potential Target for MicroRNAs in Cardiometabolic Disease. Curr Hypertens Rep. 2022;24(5):145–56.
22.
HuangL, YangL, DingY, JiangX, XiaZ, YouZ. Human umbilical cord mesenchymal stem cells-derived exosomes transfers microRNA-19a to protect cardiomyocytes from acute myocardial infarction by targeting SOX6. Cell Cycle. 2020;19(3):339–53.
23.
ZhangY, WangS, GuoS, ZhangX, YangC, SuG, et al.Circ_0004104 participates in the regulation of ox-LDL-induced endothelial cells injury via miR-942-5p/ROCK2 axis. BMC Cardiovasc Disord. 2022;22(1):517.
ChenY, WangX. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res. 2020;48(D1):D127–D31.
26.
StichtC, De La TorreC, ParveenA, GretzN. miRWalk: An online resource for prediction of microRNA binding sites. PLoS One. 2018;13(10):e0206239.
27.
LivakKJ, SchmittgenTD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–8.
28.
WangL, ZhangX, ShengJ, ChenL, ZhiL, ZhengQ, et al.RBM4 regulates cellular senescence via miR1244/SERPINE1 axis. Cell Death Dis. 2023;14(1):27.
29.
MatschkeK, JungF. Regulation of the myocardial microcirculation. Clin Hemorheol Microcirc. 2008;39(1-4):265–79.
30.
FanY, ChenY, ZhangJ, YangF, HuY, ZhangL, et al.Protective Role of RNA Helicase DEAD-Box Protein 5 in Smooth Muscle Cell Proliferation and Vascular Remodeling. Circ Res. 2019;124(10):e84–e100.
31.
Kruger-GengeA, BlockiA, FrankeRP, JungF. Vascular Endothelial Cell Biology: An Update. Int J Mol Sci. 2019;20(18).
32.
NabelEG, BraunwaldE. A tale of coronary artery disease and myocardial infarction. N Engl J Med. 2012;366(1):54–63.
33.
SonDJ, JungYY, SeoYS, ParkH, LeeDH, KimS, et al.Interleukin-32alpha Inhibits Endothelial Inflammation, Vascular Smooth Muscle Cell Activation, and Atherosclerosis by Upregulating Timp3 and Reck through suppressing microRNA-205 Biogenesis. Theranostics. 2017;7(8):2186–203.
34.
LiuJ, DongW, GaoC, MengY. Salvianolic Acid B Protects Cardiomyocytes from Ischemia/Reperfusion Injury by Mediating circTRRAP/miR-214-3p/SOX6 Axis. Int Heart J. 2022;63(6):1176–86.
